Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Board Changes

8 Apr 2026 07:00

RNS Number : 5405Z
Renishaw PLC
08 April 2026
 

Board Changes

 

Renishaw plc ("Company"), a leading provider of manufacturing technologies, analytical instruments and medical devices, announces the following changes to its Board of Directors ("Board").

 

 

Appointment of Chief Financial Officer

 

The Company is pleased to announce that following a comprehensive search process the Board has appointed John Shipsey as Chief Financial Officer ("CFO") and Executive Director with effect from 13 April 2026. 

 

John comes with significant Board and Executive Leadership experience, having undertaken the role of CFO in various companies in the listed and private setting, including 12 years at Dyson Limited, 5 years at Smiths Group plc and 2 years at Featurespace Limited. John also held finance and strategy roles at Diageo plc earlier in his career and served as a Non-executive Director of Dechra Pharmaceuticals PLC.

 

Sir David Grant, Interim Chair, commented "I would like to warmly welcome John to Renishaw and its Board. John brings a deep understanding of the industrials sector and its associated performance drivers. He has a strong track record of leading high-performing finance functions, and we look forward to him strengthening both the Board and Executive Leadership team."

 

 

Appointment of Chair

 

The Company also announces that the Board has decided to appoint Sir David Grant as its permanent Chair with immediate effect for a period of up to two years. The Board considers that Sir David has consistently demonstrated the competencies and leadership required of the Chair and his permanent appointment is in the best interests of the Company and its shareholders at this time. Sir David will retain his role as Chair of the Nomination Committee.

 

The search process for the Company's next Chair will continue with the aim of making an appointment by 2028. The Company is also continuing its search for an additional Independent Non-executive Director.

 

 

Appointment of Senior Independent Director

 

Following the appointment of Chair, the Company is also pleased to announce that Juliette Stacey has been appointed to the role of Senior Independent Director with immediate effect. Juliette was originally appointed as an Independent Non-executive Director of the Company on 1 January 2022 and has been Chair of the Audit Committee and served as a member of the Nomination and Remuneration Committees since her appointment.

 

There is no further information to be disclosed for the purposes of UK Listing Rule 6.4.8R.

 

Kasim Hussain

Group General Counsel & Company Secretary

8 April 2026

 

 

 

Renishaw plc

Registered office:

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number:

01106260, England and Wales

Telephone:

+44 (0)1453 524524

Website:

www.renishaw.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKDLFBQZLEBBD
Date   Source Headline
22nd Sep 20203:11 pmRNSReplacement Director/PDMR Shareholding
22nd Sep 20202:19 pmRNSDirector/PDMR Shareholding
8th Sep 20204:35 pmRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSAnnual Financial Report
27th Aug 20207:00 amRNSDirector/PDMR Shareholding
17th Aug 20203:15 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSFinal Results
6th Aug 202010:00 amRNSNotice of Results
17th Jul 20208:06 amRNSTrading Statement
26th Jun 20201:08 pmRNSDirector/PDMR Shareholding
24th Jun 20203:35 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:17 pmRNSDirector/PDMR Shareholding
10th Jun 20202:00 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNS2020 Final Dividend
12th May 20207:00 amRNSTrading Statement
4th May 202012:00 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20204:30 pmRNSStatement re 2019 AGM resolution votes
25th Mar 20204:28 pmRNSStatement re Interim dividend
6th Mar 20209:36 amRNSDirector/PDMR Shareholding
27th Feb 20204:47 pmRNSStatement re Interim dividend
30th Jan 20207:00 amRNSHalf-year Report
29th Jan 20205:45 pmRNSChange in Director's Responsibilities
20th Jan 202012:00 pmRNSNotice of Half-year Results
17th Jan 20209:47 amRNSHolding(s) in Company
24th Oct 20193:37 pmRNSResult of AGM
15th Oct 20197:00 amRNSTrading Statement
30th Aug 20193:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20197:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSFinal Results
16th Jul 20193:00 pmRNSNotice of Results
25th Jun 20197:00 amRNSDirectorate Change
14th May 201910:00 amRNSDirector Declaration
14th May 20197:00 amRNSTrading Statement
27th Mar 201911:36 amRNSDirector/PDMR Shareholding
22nd Mar 20199:48 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSTrading Statement
12th Mar 20194:00 pmRNSNotice of Investor Day
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20193:00 pmRNSNotice of Half-year Results
19th Dec 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 20189:56 amRNSDirector/PDMR Shareholding
23rd Oct 201810:02 amRNSDirector/PDMR Shareholding
22nd Oct 201810:43 amRNSDirector/PDMR Shareholding
18th Oct 20184:02 pmRNSResult of AGM
18th Oct 20187:00 amRNSTrading Statement
23rd Aug 20182:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20187:00 amRNSAnnual Financial Report
3rd Aug 201812:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20183:00 pmRNSDirector Declaration
26th Jul 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.